PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Macrogol compound - Faecal impaction (children)

PAD Profile : Macrogol compound - Faecal impaction (children)

Brand Names Include :
Laxido paediatric, Movicol paediatric, CosmoCol paediatric, Moviprep, Plenvu

Traffic Light Status

Status 1 of 3.

Status :
Green
Important
Formulations :
  • Sachets (powder)
Important Information :
Prescribe as macrogol compound half-strength oral powder sachets. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
SA
Documents :

Status 2 of 3.

Status :
Red
Important
Formulations :
  • Sachets (powder)
Important Information :
Moviprep. Off-label for faecal impaction. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
SA
Un
Documents :

Status 3 of 3.

Status :
Red
Important
Formulations :
  • Sachets (powder)
Important Information :
Plenvu. MHRA/CHM advice: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Un
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

No committee recommendations returned.

Associated BNF Codes

01. Gastro-Intestinal System
01.06.04. Osmotic laxatives
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More